DM
KNSA icon

Deerfield Management’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Deerfield Management’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,274,086
Closed -$10.8M – 90
2019
Q3 		$10.8M Sell
1,274,086
-36,173
-3% -$400K 0.44% 58
2019
Q2 		$17.7M Hold
1,310,259
– – 0.64% 54
2019
Q1 		$23.7M Buy
1,310,259
+181,437
+16% +$3.5M 0.91% 37
2018
Q4 		$31.7M Buy
1,128,822
+66,866
+6% +$1.4M 1.27% 29
2018
Q3 		$27.1M Sell
1,061,956
-164,934
-13% -$3.21M 0.97% 38
2018
Q2 		$21.3M Buy
+1,226,890
New +$22.2M 0.75% 53

Other funds holding KNSA

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Deerfield Management's KNSA Position: Q4 2019 in Review

Deerfield Management sold out of Kiniksa Pharmaceuticals (KNSA) in Q4 2019, closing a stake of 1,274,086 shares — an estimated $10.8M sold.

Deerfield Management first reported a position in KNSA in Q2 2018 and held it in 6 quarters. The position peaked at $31.7M in Q4 2018. 62 funds tracked by Wall St. Rank hold KNSA as of Q4 2019.

  • Deerfield Management reported no remaining Kiniksa Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Deerfield Management sold 1,274,086 Kiniksa Pharmaceuticals shares in Q4 2019, an estimated $10.8M.
  • Deerfield Management first reported a position in Kiniksa Pharmaceuticals in Q2 2018 and held it in 6 quarters.
  • Deerfield Management's Kiniksa Pharmaceuticals position peaked at $31.7M in Q4 2018.
  • 62 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q4 2019.

Based on Deerfield Management's 13F filing for Q4 2019, filed 14 Feb 2020.